Metabolism mechanism of glycosaminoglycans by the gut microbiota: Bacteroides and lactic acid bacteria: A review

Carbohydr Polym. 2024 May 15:332:121905. doi: 10.1016/j.carbpol.2024.121905. Epub 2024 Feb 5.

Abstract

Glycosaminoglycans (GAGs), as a class of biopolymers, play pivotal roles in various biological metabolisms such as cell signaling, tissue development, cell apoptosis, immune modulation, and growth factor activity. They are mainly present in the colon in free forms, which are essential for maintaining the host's health by regulating the colonization and proliferation of gut microbiota. Therefore, it is important to explain the specific members of the gut microbiota for GAGs' degradation and their enzymatic machinery in vivo. This review provides an outline of GAGs-utilizing entities in the Bacteroides, highlighting their polysaccharide utilization loci (PULs) and the enzymatic machinery involved in chondroitin sulfate (CS) and heparin (Hep)/heparan sulfate (HS). While there are some variations in GAGs' degradation among different genera, we analyze the reputed GAGs' utilization clusters in lactic acid bacteria (LAB), based on recent studies on GAGs' degradation. The enzymatic machinery involved in Hep/HS and CS metabolism within LAB is also discussed. Thus, to elucidate the precise mechanisms utilizing GAGs by diverse gut microbiota will augment our understanding of their effects on human health and contribute to potential therapeutic strategies for diseases.

Keywords: Bacteroides; Enzymatic machinery; Glycosaminoglycans; Lactic acid bacteria; Polysaccharide utilization loci.

Publication types

  • Review

MeSH terms

  • Bacteroides / metabolism
  • Gastrointestinal Microbiome*
  • Glycosaminoglycans / metabolism
  • Heparin
  • Heparitin Sulfate
  • Humans
  • Lactobacillales* / metabolism

Substances

  • Glycosaminoglycans
  • Heparin
  • Heparitin Sulfate